The US Food and Drug Administration (FDA) has approved Medtronic’s Altaviva device, intended for the treatment of urge urinary incontinence. This implantable tibial neuromodulation (ITNM) device ...
Neuspera Medical has reported encouraging 12-month pivotal trial results for its integrated sacral neuromodulation system (iSNM), Neuspera SNM, in patients with urinary urge incontinence (UUI). The ...
After implantation, patients are able to return home with the therapy activated; no daily interventions or manual adjustments are required. The Food and Drug Administration (FDA) has cleared Medtronic ...
Amber Therapeutics Ltd. revealed positive data from the first-in-human investigation of its Amber-UI device, an implantable closed-loop bioelectrical therapy for urinary incontinence. Initial results ...
Zynex has announced it received FDA clearance for a new device used primarily for treating female urinary incontinence, according to a news release. The InWave medical device will be manufactured, ...
Relief Srl raised more than €1 million (US$1.08 million) in financing for Urorelief, its endourethral medical device which treats stress urinary incontinence. The Italian startup will use the funds to ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...
The majority of adult women in the US suffer urinary incontinence (UI), with the most common form of UI being Stress Urinary Incontinence (SUI), which is often caused by weak pelvic floor muscles. SUI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results